These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 1448646)

  • 41. New variant Creutzfeldt-Jakob disease and bovine pituitary growth hormone.
    Verdrager J
    Lancet; 1998 Jan; 351(9096):112-3. PubMed ID: 9439502
    [No Abstract]   [Full Text] [Related]  

  • 42. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

  • 43. Human pituitary growth hormone (hGH) and Creutzfeldt-Jakob disease: results of an epidemiological survey in France, 1986.
    Goujard J; Entat M; Maillard F; Mugnier E; Rappaport R; Job JC
    Int J Epidemiol; 1988 Jun; 17(2):423-7. PubMed ID: 3042652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
    Buchanan CR; Preece MA; Milner RD
    BMJ; 1991 Apr; 302(6780):824-8. PubMed ID: 2025705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment.
    Hintz RL
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2298-301. PubMed ID: 7629222
    [No Abstract]   [Full Text] [Related]  

  • 46. Human growth hormone treatment and Creutzfeldt-Jakob disease.
    Sartorio A; Arosio M; Faglia G; Resentini M; Morabito F
    J Endocrinol Invest; 1986 Oct; 9(5):439. PubMed ID: 3540083
    [No Abstract]   [Full Text] [Related]  

  • 47. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases.
    Brown P
    Ciba Found Symp; 1988; 135():3-23. PubMed ID: 3044708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal proteins in the cerebrospinal fluid of a patient with Creutzfeldt-Jakob disease following administration of human pituitary growth hormone.
    Macário ME; Moura-Neto V; Vaisman M; Araujo HM; Buescu A; Cordeiro JG; Chagas C
    Braz J Med Biol Res; 1992; 25(11):1127-30. PubMed ID: 1342593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.
    Koch TK; Berg BO; De Armond SJ; Gravina RF
    N Engl J Med; 1985 Sep; 313(12):731-3. PubMed ID: 3897861
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.
    Holmes SJ; Ironside JW; Shalet SM
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):333-5. PubMed ID: 8609514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study.
    Markus HS; Duchen LW; Parkin EM; Kurtz AB; Jacobs HS; Costa DC; Harrison MJ
    Q J Med; 1992 Jan; 82(297):43-51. PubMed ID: 1438667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine.
    Brown P; Cervenáková L; Goldfarb LG; McCombie WR; Rubenstein R; Will RG; Pocchiari M; Martinez-Lage JF; Scalici C; Masullo C
    Neurology; 1994 Feb; 44(2):291-3. PubMed ID: 8309577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical review 58: Creutzfeldt-Jakob disease in recipients of pituitary hormones.
    Frasier SD; Foley TP
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1277-9. PubMed ID: 8200924
    [No Abstract]   [Full Text] [Related]  

  • 54. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone.
    Croes EA; Roks G; Jansen GH; Nijssen PC; van Duijn CM
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):792-3. PubMed ID: 12023427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors Influencing the Incubation of an Infectious Form of Creutzfeldt-Jakob Disease.
    Peckeu L; Brandel JP; Welaratne A; Amar E; Costagliola D; Haïk S
    Clin Infect Dis; 2020 Mar; 70(7):1487-1490. PubMed ID: 31351441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease.
    Deslys JP; Lasmézas C; Dormont D
    Lancet; 1994 Apr; 343(8901):848-9. PubMed ID: 7908088
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current topics of prion disease].
    Furukawa H; Doh-ura K
    Uirusu; 2001 Dec; 51(2):151-8. PubMed ID: 11977755
    [No Abstract]   [Full Text] [Related]  

  • 58. [Growth hormone. Human or biosynthetic?].
    Beas F
    Rev Chil Pediatr; 1987; 58(2):113-6. PubMed ID: 3328235
    [No Abstract]   [Full Text] [Related]  

  • 59. Valine homozygous 129 PrP genotype in a French growth-hormone-related Creutzfeldt-Jakob disease patient.
    Labauge P; Pagès M; Blard JM; Chatelain J; Laplanche JL
    Neurology; 1993 Feb; 43(2):447. PubMed ID: 8437720
    [No Abstract]   [Full Text] [Related]  

  • 60. A nationwide cohort study on Creutzfeldt-Jakob disease among human growth hormone recipients.
    Wientjens DP; Rikken B; Wit JM; Hofman A; Stricker BH
    Neuroepidemiology; 2000; 19(4):201-5. PubMed ID: 10859499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.